dimer

(redirected from Homodimerization)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Homodimerization: dimeric, Homodimers, Heterodimerization

di·mer

 (dī′mər)
n.
A chemical compound or molecule consisting of two identical simpler molecules.


di·mer′ic (dī-mĕr′ĭk) adj.

dimer

(ˈdaɪmə)
n
(Chemistry) chem
a. a molecule composed of two identical simpler molecules (monomers)
b. a compound consisting of dimers
[C20: from di-1 + -mer]

di•mer

(ˈdaɪ mər)

n.
1. a molecule composed of two identical, simpler molecules.
2. a polymer derived from two identical monomers.
[1905–10]
di•mer′ic (-ˈmɛr ɪk) adj.

di·mer

(dī′mər)
Any of various chemical compounds made of two smaller, identical molecules (called monomers) that are linked together.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.dimer - a compound whose molecules are composed of two identical monomersdimer - a compound whose molecules are composed of two identical monomers
chemical compound, compound - (chemistry) a substance formed by chemical union of two or more elements or ingredients in definite proportion by weight
Translations
References in periodicals archive ?
These cytokines bind to their cognate receptors and induce either homodimerization of gp130 (common signal transducer) or heterodimerization of gp130 and one of its partners, such as LIFR[beta].
Homodimerization is mediated by repeat 24 nearest to the C-terminal.
Homodimerization and heterodimerization of the glomerular podocyte proteins nephrin and NEPH1.
The BTB domain is responsible for homodimerization of Keap1 and the Kelch domain mediates the interaction with ETGE and DLG motifs in Neh2 domain of
ToxCast and Tox21 contain several assays intended to evaluate chemicals' effects on steroid hormone signaling pathways, including a diverse group of ER end points (ERa and ERP hetero- and homodimerization, binding, transcriptional activity, and proliferation in an estrogen-dependent breast cancer cell line) (Judson et al.
Extracellular ligand binding triggers homodimerization or heterodimerization of ErbB family receptors, phosphorylating active sites in the cytoplasmic tyrosine kinase, and activating intracellular PI3K/AKT/mTOR and RAS/RAF/MAPK pathways.
These include the N-terminal domain responsible for ATP binding, a proteolytically resistant and the C-terminal core domain that facilitates homodimerization (Terasawa K.